1 document found, page 1 of 1

Sort by Issue Date
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

Risk of Death After Paclitaxel Exposure During Femoropopliteal Artery Angioplas...

Ribeiro, T; Soares Ferreira, R; Cardoso, J; Figueiredo, A; Fidalgo, H; Bastos Gonçalves, F; Ferreira, ME

Paclitaxel molecule has been on the market since 1991 and is indicated for the treatment of multiple neoplasms. Since 2012 has been used in endovascular devices for the treatment of peripheral artery disease and have become a mainstay in the treatment of symptomatic femoro-popliteal lesions, in particular for preventing arterial restenosis. They have a proven benefit in patency and freedom-from re-intervention ...

Date: 2021   |   Origin: Repositório do Centro Hospitalar de Lisboa Central, EPE
More info.
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

1 Results

Queried text

Refine Results

Author








Date


Document Type


Access rights


Resource


Subject